FNS  Vol.5 No.22 , December 2014
Nutrigenomic Study on Immunomodulatory Function of Cordyceps Mycelium Extract (Paecilomyces hepiali) in Mitomycin C–Treated Mice
Abstract: Cordyceps (CS) is a Chinese herb that produces various effects including immune modulation, and now CS culture product is interested in the use as a functional food. We prepared CS mycelium culture extract (Paecilomyces hepiali, CBG-CS-2), CS extract, for functional foods. This study aimed to deduce the molecular mechanism of immunomodulatory effect of CS extract in Peyer’s patches (PPs), a main gut immune site, in mice that treated with mitomycin C (MMC), an immunosuppressing antibiotics. Nutrigenomics give us invaluable molecular information about both of foods and nutrition to improve or maintain good health. Here we performed nutrigenomics using DNA microarray to investigate the effect of CS extract on gene expression altered in PPs of the immunosuppressed mice. Interestingly, CS extract protected from the MMC-mediated downregulation of 22 genes, which are associated with IgA production and other immune response in PPs. These suggested that CS extract alleviated the downregulated expression of immune related genes in the gut immune site in an immunosuppressed state. Thus CS extract appears to be practical functional food for immunodepression and/or its related hypofunction.
Cite this paper: Chae, S. , Mitsunaga, F. , Jung, S. , Ha, K. , Sin, H. , Jang, S. and Nakamura, S. (2014) Nutrigenomic Study on Immunomodulatory Function of Cordyceps Mycelium Extract (Paecilomyces hepiali) in Mitomycin C–Treated Mice. Food and Nutrition Sciences, 5, 2217-2224. doi: 10.4236/fns.2014.522235.

[1]   Afman, L. and Müller, M. (2006) Nutrigenomics: From Molecular Nutrition to Prevention of Disease. Journal of the American Dietetic Association, 106, 569-576.

[2]   Liu, B. and Qian, S.B. (2011) Translational Regulation in Nutrigenomics. Advances in Nutrition, 2, 511-519.

[3]   Thunders, M., Mangai, S. and Cooper, R. (2013) Nutrigenetics, Nutrigenomics, and the Future of Dietary Advice. Food and Nutrition Sciences, 4, 999-1003.

[4]   Paterson, R.R. (2008) Cordyceps: A Traditional Chinese Medicine and Another Fungal Therapeutic Biofactory? Phytochemistry, 69, 1469-1495.

[5]   Zhou, X., Gong, Z., Su, Y., Lin, J. and Tang, K. (2009) Cordyceps Fungi: Natural Products, Pharmacological Functions and Developmental Products. The Journal of Pharmacy and Pharmacology, 61, 279-291.

[6]   Shin, S., Kwon, J., Lee, S., Kong, H., Lee, S., Lee, C.K., et al. (2010) Immunostimulatory Effects of Cordyceps militaris on Macrophages through the Enhanced Production of Cytokines via the Activation of NF-κB. Immune Network, 10, 55-63.

[7]   Li, S.P., Yang, F.Q. and Tsim, K.W.K. (2006) Quality Control of Cordyceps sinensis, a Valued Traditional Chinese Medicine. Journal of Pharmaceutical and Biomedical Analysis, 41, 1571-1584.

[8]   Yue, K., Ye, M., Zhou, Z., Sun, W. and Lin, X. (2013) The Genus Cordyceps: A Chemical and Pharmacological Review. The Journal of Pharmacy and Pharmacology, 65, 474-493.

[9]   Lo, H.C., Hsu, T.H., Tu, S.T. and Lin, K.C. (2006) Anti-Hyperglycemic Activity of Natural and Fermented Cordyceps sinensis in Rats with Diabetes Induced by Nicotinamide and Streptozotocin. The American Journal of Chinese Medicine, 34, 819-832.

[10]   Xiao, J.H., Li, Y., Xiao, Y. and Zhong, J.J. (2013) Advance and Prospect of Studies on Bioactivity and Mechanism of Cordyceps Fungi. Zhongguo Zhong Yao Za Zhi, 38, 640-647.

[11]   Yan, W., Li, T., Lao, J., Song, B. and Shen, Y.H. (2013) Anti-Fatigue Property of Cordyceps guangdongensis and the Underlying Mechanisms. Pharmaceutical Biology, 51, 614-620.

[12]   Kim, H.O. and Yun, J.W. (2005) A Comparative Study on the Production of Exopolysaccharides between Two Entomopathogenic Fungi Cordyceps militaris and Cordyceps sinensis in Submerged Mycelial Cultures. Journal of Applied Microbiology, 99, 728-738.

[13]   Xu, C.P., Sinha, J., Bae, J.T., Kim, S.W. and Yun, J.W. (2006) Optimization of Physical Parameters for Exo-Biopolymer Production in Submerged Mycelial Cultures of Two Entomopathogenic Fungi Paecilomyces japonica and Paecilomyces tenuipes. Letters in Applied Microbiology, 42, 501-506.

[14]   Doe, W.F. (1989) The Intestinal Immune System. Gut, 30, 1679-1685.

[15]   Walker, R.L. and Owen, R.L. (1990) Intestinal Barriers to Bacteria and Their Toxins. Annual Review of Medicine, 41, 393-400.

[16]   Lycke, N.Y. and Bemark, M. (2012) The Role of Peyer’s Patches in Synchronizing Gut IgA Responses. Frontiers in Immunology, 3, 329.

[17]   Sato, A. and Iwasaki, A. (2005) Intestinal Epithelial Barrier and Mucosal Immunity. Cellular and Molecular Life Sciences, 62, 1333-1338.

[18]   Hashizume, T., Togawa, A., Nochi, T., Igarashi, O., Kweon, M.N., Kiyono, H. and Yamamoto, M. (2008) Peyer’s Patches Are Required for Intestinal Immunoglobulin A Responses to Salmonella spp. Infection and Immunity, 76, 927-934.

[19]   Yamaguchi, Y., Mori, K. and Bollinger, R.R. (1990) Suppression of Hepatic Allograft Rejection in the Rat by Mitomycin C-Treated Donor Splenocytes: Analysis of the Immune Status. Journal of Clinical & Laboratory Immunology, 32, 59-66.

[20]   Micheau, O., Solary, E., Hammann, A., Martin, F. and Dimanche-Boitrel, M.T. (1997) Sensitization of Cancer Cells Treated with Cytotoxic Drugs to Fas-Mediated Cytotoxicity. Journal of the National Cancer Institute, 89, 783-789.

[21]   Volpato, M. and Phillips, R.M. (2007) Tailoring Targeted Therapy to Individual Patients: Lessons to Be Learnt from the Development of Mitomycin C. Cancer Genomics & Proteomics, 4, 175-186.

[22]   Li, A.L., Komatsu, Y., Ono, Y., Nakatani, F., Nakashima, K. and Yamaguchi, N. (1996) The Effect of Herbal Medicines on the Immunodeficient Animals by Injecting Cancer Chemotherapeutic Agent-Special Reference to Age Related Recovery of the Function. Kansenshogaku Zasshi, 70, 717-726.

[23]   Jeong, A.R., Nakamura, S. and Mitsunaga, F. (2008) Gene Expression Profile of Th1 and Th2 Cytokines and Their Receptors in Human and Nonhuman Primates. Journal of Medical Primatology, 37, 290-296.

[24]   Shippy, R., Fulmer-Smentek, S., Jensen, R.V., Jones, W.D., Wolber, P.K., Johnson, C.D., et al. (2006) Using RNA Sample Titrations to Assess Microarray Platform Performance and Normalization Techniques. Nature Biotechnology, 24, 1123-1131.

[25]   Li, C.Y., Chiang, C.S., Tsai, M.L., Hseu, R.S., Shu, W.Y., Chuang, C.Y., et al. (2009) Two-Sided Effect of Cordyceps sinensis on Dendritic Cells in Different Physiological Stages. Journal of Leukocyte Biology, 85, 987-995.

[26]   Lin, B.Q. and Li, S.P. (2011) Chapter 5. Cordyceps as an Herbal Drug. In: Benzie, F.F. and Wachtel-Galor, S., Eds., Herbal Medicine: Biomolecular and Clinical Aspects, 2nd Edition, CRC Press, Boca Raton, 73-105.

[27]   Trapani, J.A. and Smyth, M.J. (2002) Functional Significance of the Perforin/Granzyme Cell Death Pathway. Nature Reviews Immunology, 2, 735-747.

[28]   Cupedo, T. (2011) Human Lymph Node Development: An Inflammatory Interaction. Immunology Letters, 138, 4-6.

[29]   Yang, L.Y., Chen, A., Kuo, Y.C. and Lin, C.Y. (1999) Efficacy of a Pure Compound H1-A Extracted from Cordyceps sinensis on Autoimmune Disease of MRL lpr/lpr Mice. The Journal of Laboratory and Clinical Medicine, 134, 492-500.

[30]   Kuo, Y.C., Tsai, W.J., Wang, J.Y., Chang, S.C., Lin, C.Y. and Shiao, M.S. (2001) Regulation of Bronchoalveolar Lavage Fluids Cell Function by the Immunomodulatory Agents from Cordyceps sinensis. Life Sciences, 68, 1067-1082.

[31]   Yanagibashi, T., Hosono, A., Oyama, A., Tsuda, M., Hachimura, S., Takahashi, Y., et al. (2009) Bacteroides Induce Higher IgA Production than Lactobacillus by Increasing Activation-Induced Cytidine Deaminase Expression in B Cells in Murine Peyer’s Patches. Bioscience, Biotechnology, and Biochemistry, 73, 372-377.

[32]   Maeda, S., Ohno, K., Fujiwara-Igarashi, A., Tomiyasu, H., Fujino, Y. and Tsujimoto, H. (2014) Methylation of TNFRSF13B and TNFRSF13C in Duodenal Mucosa in Canine Inflammatory Bowel Disease and Its Association with Decreased Mucosal IgA Expression. Veterinary Immunology and Immunopathology, 160, 97-106.

[33]   Tezuka, H., Abe, Y., Iwata, M., Takeuchi, H., Ishikawa, H., Matsushita, M., et al. (2007) Regulation of IgA Production by Naturally Occurring TNF/iNOS-Producing Dendritic Cells. Nature, 448, 929-933.

[34]   De Calisto, J., Wang, N., Wang, G., Yigit, B., Engel, P. and Terhorst, C. (2014) SAP-Dependent and -Independent Regulation of Innate T Cell Development Involving SLAMF Receptors. Frontiers in Immunology, 5, 186.

[35]   Bai, Z., Hayasaka, H., Kobayashi, M., Li, W., Guo, Z., Jang, M.H., et al. (2009) CXC Chemokine Ligand 12 Promotes CCR7-Dependent Naive T Cell Trafficking to Lymph Nodes and Peyer’s Patches. Journal of Immunology, 182, 1287-1295.

[36]   Yokouchi, M., Suzuki, R., Masuhara, M., Komiya, S., Inoue, A. and Yoshimura, A. (1997) Cloning and Characterization of APS, an Adaptor Molecule Containing PH and SH2 Domains that Is Tyrosine Phosphorylated upon B-Cell Receptor Stimulation. Oncogene, 15, 7-15.

[37]   Kroll, J., Shi, X., Caprioli, A., Liu, H.H., Waskow, C., Lin, K.M., et al. (2005) The BTB-Kelch Protein KLHL6 is Involved in B-Lymphocyte Antigen Receptor Signaling and Germinal Center Formation. Molecular and Cellular Biology, 25, 8531-8540.

[38]   Walter, W., Scheuer, C., Lingnau, K., Reichert, T.E., Schmitt, E., Loos, M. and Maeurer, M.J. (2000) H2-M, a Facilitator of MHC Class II Peptide Loading, and Its Negative Modulator H2-O Are Differentially Expressed in Response to Proinflammatory Cytokines. Immunogenetics, 51, 794-804.